The earnings call presented a balanced view of IFF's performance with solid financial results, successful divestitures, and strategic initiatives for share repurchases. However, challenges remain in the Health & Bioscience segment and Fragrance Ingredients, influenced by market dynamics and competitive pressures.

Company Guidance -

Q3 2025

In the IFF Second Quarter 2025 earnings call, the company reported a 3% increase in sales to over $2.75 billion, with adjusted operating EBITDA increasing by 6% to $552 million. The net debt-to-EBITDA ratio was reduced to 2.5x, surpassing the target of less than 3x. The company completed the divestitures of its Pharma Solutions and Nitrocellulose businesses, improving its financial position. The divestment of the Soy Crush, Concentrates, and Lecithin business to Bunge was also announced, aimed at reaching a mid-teens EBITDA margin goal for its food ingredients business. IFF introduced a $500 million share repurchase authorization, affirming confidence in its future. For 2025, IFF maintained its sales guidance range of $10.6 billion to $10.9 billion, with adjusted operating EBITDA expected to be between $2 billion and $2.15 billion, reflecting a 5% to 10% currency-neutral growth. Despite a challenging environment and strong prior year comparisons, IFF remains optimistic about meeting its targets and anticipates increased impact from strengthening R&D pipelines from 2026 onwards.

Solid Financial Performance

IFF achieved 3% sales growth and 7% adjusted operating EBITDA growth in the first half of 2025. Net debt-to-EBITDA reduced to 2.5x, the first time below 3.0x since 2018.

Successful Divestitures

Completed divestitures of Pharma Solutions and Nitrocellulose businesses. Announced divestiture of Soy Crush, Concentrates, and Lecithin business to Bunge.

New Share Repurchase Program

Announced a $500 million share repurchase authorization to return capital to shareholders.

Strong Segment Performance

Pharma Solutions delivered sales of $103 million, a 21% increase year-over-year. Taste segment recorded 6% sales growth, and Food Ingredients delivered a 21% increase in profitability.

International Flavors & Fragrances (IFF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

IFF Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	1.02 / -	1.04	―	―	―
Aug 05, 2025	2025 (Q2)	1.12 / 1.15	1.16	-0.86% (-0.01)
May 06, 2025	2025 (Q1)	1.14 / 1.20	1.13	6.19% (+0.07)
Feb 18, 2025	2024 (Q4)	0.81 / 0.97	0.72	34.72% (+0.25)
Nov 05, 2024	2024 (Q3)	1.07 / 1.04	0.89	16.85% (+0.15)
Aug 06, 2024	2024 (Q2)	0.99 / 1.16	0.86	34.88% (+0.30)
May 06, 2024	2024 (Q1)	0.86 / 1.13	0.87	29.89% (+0.26)
Feb 20, 2024	2023 (Q4)	0.76 / 0.72	0.97	-25.77% (-0.25)
Nov 06, 2023	2023 (Q3)	0.75 / 0.89	1.36	-34.56% (-0.47)
Aug 07, 2023	2023 (Q2)	1.10 / 0.86	1.54	-44.16% (-0.68)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

IFF Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$70.62	$66.16	-6.32%
May 06, 2025	$78.78	$73.20	-7.08%
Feb 18, 2025	$85.56	$81.14	-5.17%
Nov 05, 2024	$97.62	$86.26	-11.64%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.